Testing spinal manipulative therapy for chronic low-back pain
Official title: The METRIC Study Protocol: an Explanatory Randomized Controlled Trial Investigating the Neurophysiological Mechanisms Underlying the Therapeutic Effects of Spinal Manipulative Therapy for Chronic Primary Low Back Pain
Run by Université du Québec à Trois-Rivières · NCT05986370 · Data updated 2026-11-12
This study tests if spinal manipulative therapy can help people with chronic low back pain feel better and if different types of treatment make a difference.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 60 Years |
| Sex | All |
| Enrollment | 112 (estimated) |
| Sponsor | Université du Québec à Trois-Rivières Academic / other |
| Locations | 1 site (Trois-Rivières, Quebec) |
| Status | Recruiting |
| Started | October 25, 2023 |
| Main results expected | September 29, 2025 |
| Study ends | December 31, 2026 |
| Registry record updated | December 4, 2023 |
| Trial ID | NCT05986370 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals experiencing chronic primary low back pain for at least six months with moderate pain intensity.
✕Probably not a fit
Patients with other specific back conditions or severe pain in other body locations may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the effects of spinal manipulative therapy on individuals suffering from chronic primary low back pain. It will investigate whether pain relief is linked to a reduction in C-fiber-related nociceptive processing and whether treatment outcomes differ based on the extent of spinal manipulation applied. Participants will receive either full spine or lumbar-only spinal manipulative therapy, or a control intervention, over varying treatment durations. Healthy volunteers will also be included to provide reference data for comparison.
Why it matters
Potential benefit: If successful, this study could lead to more effective pain management strategies for patients with chronic low back pain.
How similar studies have gone: Previous studies have shown promising results with spinal manipulative therapy for similar conditions, suggesting potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Duration of current low back pain (LBP) episode ≥ 6 months; * Average LBP intensity during the last 7 days ≥ 3/10; * (For healthy volunteers only) To be of the same sex and age (± 1 year) as a participant with low back pain. Exclusion Criteria: * Diagnosis of back conditions other than chronic primary LBP e.g., failed back surgery syndrome, spondylosis, spondylolisthesis, spinal stenosis, herniated disc, infection, etc.; * Presence of pain in another body location that is more severe than the pain in the lower back; * Presence of a neurological deficit i.e., sensation loss, muscle weakness, decreased deep tendon reflexes; * Presence of contraindications to spinal manipulative therapy e.g., recent fracture, history of spinal surgery, cauda equina syndrome, inflammatory arthritis, taking anticoagulant medication, active cancer, moderate to severe osteoporosis, abdominal aortic aneurysm; * Underwent surgery in the last 3 months; * Pregnancy, ≤ 3 months post-partum or planning to get pregnant in the next 12 months; * History of spinal manipulative therapy in the past 12 months; * Scoliosis ≥ 20°; * BMI ≥ 40; * Insufficient language skills in French to complete the questionnaires; * Open or pending litigation for LBP or seeking/receiving disability compensation; * Diagnosis of an illness affecting the sensorimotor functions e.g., diabetes, multiple sclerosis, amyotrophic lateral sclerosis; * Diagnosis of mental health disorders (with the exception of anxiety and depression); * Current drug or alcohol dependence; * Skin of type I on the Fitzpatrick scale; * (For healthy volunteers only) Regular use of pain medication or usage in the 48 h prior to data collection; * (For healthy volunteers only) History of chronic pain; * (For healthy volunteers only) Acute pain on the days of data collection.
Where it's running
-
Université du Québec à Trois-Rivières
Trois-Rivières, Quebec, Canada Recruiting
Study contacts
- Principal investigator: Mathieu Piché — Université du Québec à Trois-Rivières
- Study coordinator: Benjamin Provencher
- Email: metric@uqtr.ca
- Phone: 1-819-376-5011
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ultrasound-Guided Thoracolumbar Fascia Injection for Chronic Low Back Pain in Type 2 Diabetes
This trial tests whether an ultrasound-guided injection into the thoracolumbar fascia, added to standard care, helps reduce chronic low back pain in adults with type 2 diabetes.
-
Subcutaneous Fat, Back Muscles, and Spine Shape in Back Pain Patients
This study tests whether body fat under the skin and features of back muscles and spine joints are linked to lumbar facet joint degeneration in adults with chronic low back pain.
-
See if serum BDNF levels relate to outcomes in chronic low back pain
This study tests whether blood BDNF levels can help predict how patients with chronic low back pain will do over time.
-
Correlating periostin levels with spinal degeneration in back pain
This study tests whether periostin levels in the intervertebral disc relate to the severity of disc degeneration in people with chronic low back pain and spinal stenosis.
-
Palmitoylethanolamide for Central Sensitisation and Neuroinflammation in Chronic Low Back Pain
A treatment with palmitoylethanolamide is being tried to see if it helps people with chronic low back pain who have nerve-related pain and disc problems.
-
Multichannel neuromuscular stimulation plus core exercise for chronic low back pain
This study tests two multichannel neuromuscular electrical stimulation programs added to a core exercise plan to see if they help adults with chronic non-specific low back pain.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.